Stay updated on Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.
    Difference
    0.1%
    Check dated 2025-12-23T09:17:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A revision label 'Revision: v3.3.2' was added at the top of the page (replacing the previous v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:46:13.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The Publications section wording was updated to clarify that PubMed publications are auto-filled and may not pertain to the study, and the revision label was updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:35:30.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding status banner from the page; all study details, eligibility criteria, and results sections remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:27.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Minor formatting changes and an expanded Publications section were added; core study content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:11:05.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added a new bibliographic reference (NPJ Breast Cancer, 2025) about biomarkers and outcomes in metastatic TNBC treated with pembrolizumab/chemotherapy; no deletions observed.
    Difference
    2%
    Check dated 2025-10-12T14:32:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.